CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
Table 1
Main characteristics of enrolled studies.
First author
Time
Country
Age
Number of patients
Survival results
Test method
Tumor types
HR
Follow-up time
Cancer stage
Expression location
Cut-off value
NOS score
Li
2005
China
24–69
51
DFS
IHC
HCC
Univariate
5–90 months
NA
Cell surface
Positive: more than 10% of cells stained
7
Zhang
2006
China
48.52 ± 9.60
82
RFS
IHC
HCC
Multivariate
1–45 months
TNMI-
Cell surface
Positive: more than 10% of cells stained
7
Zhang
2007
China
24–66
111
RFS
IHC
HCC
Multivariate
1–63 months
TNMI-
Cell surface
NA
7
Wang
2012
China
28–65
272
OS, MST
IHC
HCC
Univariate
NA
TNMI-
Cell surface
Positive: scores ≥ 2 were positive
7
Li
2010
China
15–65
83
OS, MST
IHC
HCC
Univariate
1–101 months
TNMI-
Cell surface
Positive: more than 10%
6
Luo
2011
China
NA
180
RFS
IHC
HCC
Univariate
0–12 months
TNMI-
Cell surface
Positive: more than 5%
6
Zhang
2014
China
24–66
51
OS, MST
IHC
HCC
Univariate
2–60 months
TNMI-
Cell surface
NA
6
Zhu
2015
China
31–76
50
OS
IHC
HCC
Multivariate
0–48 months
NA
Cell surface
Positive: more than 5%
7
MST: median survival time; : the research is liver transplantation; scores: The positive cells were classified into 4 grades on the basis of the percentage of the positive cells: the number of the cells below 5% was zero score, 6%–25% was 1 score, 26%–50% was 2 score, and higher than 51% was 3 score; second the positive cells were classified into 4 grades on the basis of intensity of color: colorless was zero score, yellow was 1 score, light brown was 2 score, and deep brown was 3 score. Then the two kinds of scores were added: the score which was lower than 1 was negative and that which was higher than 2 was positive.